Biologic therapy and gene therapy in the multimodality treatment of malignant pleural mesothelioma.
暂无分享,去创建一个
[1] R. Stahel,et al. Searching for targets for the systemic therapy of mesothelioma. , 2015, Annals of oncology : official journal of the European Society for Medical Oncology.
[2] M. Wu,et al. Targeting the inhibitory receptor CTLA-4 on T cells increased abscopal effects in murine mesothelioma model , 2015, Oncotarget.
[3] Devina D Lakhiani,et al. Neoadjuvant anti-tumor vaccination prior to surgery enhances survival , 2014, Journal of Translational Medicine.
[4] J. A. McCart,et al. Oncolytic Vaccinia Virus as an Adjuvant Treatment to Cytoreductive Surgery for Malignant Peritoneal Mesothelioma , 2014, Annals of Surgical Oncology.
[5] H. Hoogsteden,et al. Immunotherapy prospects in the treatment of lung cancer and mesothelioma. , 2014, Translational lung cancer research.
[6] M. Maio,et al. Immune checkpoint blockade in malignant mesothelioma , 2014, Oncoimmunology.
[7] S. Singhal,et al. Chemotherapy delivered after viral immunogene therapy augments antitumor efficacy via multiple immune-mediated mechanisms. , 2010, Molecular therapy : the journal of the American Society of Gene Therapy.
[8] A. Chella,et al. Multimodality treatment of malignant pleural mesothelioma with or without immunotherapy: does it change anything? , 2010, Interactive cardiovascular and thoracic surgery.
[9] S. Kyo,et al. A novel translational approach for human malignant pleural mesothelioma: heparanase-assisted dual virotherapy , 2010, Oncogene.
[10] A. Nowak,et al. Chemoimmunotherapy: an emerging strategy for the treatment of malignant mesothelioma. , 2009, Tissue Antigens.
[11] Stacey Su. Mesothelioma: path to multimodality treatment. , 2009, Seminars in thoracic and cardiovascular surgery.
[12] D. Lardinois,et al. Immuno-chemotherapy reduces recurrence of malignant pleural mesothelioma: an experimental setting. , 2009, European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery.
[13] V. Rusch,et al. Radiation-Induced Cellular DNA Damage Repair Response Enhances Viral Gene Therapy Efficacy in the Treatment of Malignant Pleural Mesothelioma , 2006, Annals of Surgical Oncology.
[14] S. Steinberg,et al. A phase II trial investigating primary immunochemotherapy for malignant pleural mesothelioma and the feasibility of adjuvant immunochemotherapy after maximal cytoreduction , 1995, Annals of Surgical Oncology.
[15] S. Singhal,et al. Immuno-gene therapy with interferon-beta before surgical debulking delays recurrence and improves survival in a murine model of malignant mesothelioma. , 2004, The Journal of thoracic and cardiovascular surgery.